HIGHLIGHTS
- who: John Dempster from the London Hospital, Whitechapel, London , BB, UK have published the paper: Practicalities of a reduced volume formulation of a C1-INH concentrate for the treatment of hereditary angioedema: real-life experience, in the Journal: (JOURNAL)
- what: The authors compare the clinical experience of the reduced volume IU vial with multiple IU vials.
SUMMARY
Hereditary angioedema (HAE) is a rare autosomal genetic disorder caused by C1 esterase inhibitor (C1-INH) deficiency (type I) or dysfunction (type II). C1-INH is a serine protease inhibitor that regulates activation of . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.